{"name":"Acrotech Biopharma Inc.","slug":"acrotech-biopharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2008-01-01","label":"Fusilev first approved","drug":"Fusilev","drugSlug":"levoleucovorin","type":"approval","sentiment":"positive"},{"date":"2014-01-01","label":"Beleodaq first approved","drug":"Beleodaq","drugSlug":"belinostat","type":"approval","sentiment":"positive"},{"date":"2026-06-12","label":"Fusilev Phase 3 readout (Metastatic Esophageal Squamous Cell Carcinoma)","drug":"Fusilev","drugSlug":"fusilev","type":"phase3_readout","sentiment":"neutral"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-30","label":"Fusilev Phase 3 readout (Hepatocellular Carcinoma, Liver Transplantation)","drug":"Fusilev","drugSlug":"fusilev","type":"phase3_readout","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-02-01","label":"Fusilev Phase 3 readout (Esophageal Squamous Cell Carcinoma (ESCC), Gastroesophageal Junction Carcinoma (GEJC))","drug":"Fusilev","drugSlug":"fusilev","type":"phase3_readout","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-12-31","label":"Fusilev Phase 3 readout (Colorectal Neoplasms, Chemotherapy Effect)","drug":"Fusilev","drugSlug":"fusilev","type":"phase3_readout","sentiment":"neutral"},{"date":"2028-07-01","label":"Folotyn Phase 3 readout (Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T-cell Lymphoma)","drug":"Folotyn","drugSlug":"folotyn","type":"phase3_readout","sentiment":"neutral"},{"date":"2028-09-30","label":"Fusilev Phase 3 readout (Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer)","drug":"Fusilev","drugSlug":"fusilev","type":"phase3_readout","sentiment":"neutral"},{"date":"2028-10-31","label":"Folotyn Phase 3 readout (Peripheral T-cell Lymphoma)","drug":"Folotyn","drugSlug":"folotyn","type":"phase3_readout","sentiment":"neutral"},{"date":"2029-06-01","label":"Fusilev Phase 3 readout (Colorectal Cancer)","drug":"Fusilev","drugSlug":"fusilev","type":"phase3_readout","sentiment":"neutral"},{"date":"2030-11-01","label":"Folotyn Phase 3 readout (Peripheral T Cell Lymphoma)","drug":"Folotyn","drugSlug":"folotyn","type":"phase3_readout","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"oncology","drugs":[{"name":"Beleodaq","genericName":"belinostat","slug":"belinostat","indication":"Peripheral T-cell lymphoma","status":"marketed"},{"name":"Fusilev","genericName":"levoleucovorin","slug":"levoleucovorin","indication":"Adjunct to Fluorouracil Treatment of Colorectal Cancer","status":"marketed"},{"name":"Belinostat Injection","genericName":"Belinostat Injection","slug":"belinostat-injection","indication":"Peripheral T-cell lymphoma (PTCL)","status":"phase_3"},{"name":"Folotyn","genericName":"Folotyn","slug":"folotyn","indication":"Peripheral T-cell lymphoma","status":"discontinued"},{"name":"Folotyn and Leucovorin","genericName":"Folotyn and Leucovorin","slug":"folotyn-and-leucovorin","indication":"Relapsed or refractory peripheral T-cell lymphoma","status":"phase_2"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Vincristine Sulfate Liposome Injection plus rituximab","genericName":"Vincristine Sulfate Liposome Injection plus rituximab","slug":"vincristine-sulfate-liposome-injection-plus-rituximab","indication":"Other","status":"phase_1"},{"name":"Fusilev","genericName":"Fusilev","slug":"fusilev","indication":"Other","status":"discontinued"}]},{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"COP","genericName":"COP","slug":"cop","indication":"Chronic obstructive pulmonary disease (COPD)","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"Vitamin B12","genericName":"Vitamin B12","slug":"vitamin-b12","indication":"Vitamin B12 deficiency anemia","status":"marketed"}]}],"pipeline":[{"name":"Beleodaq","genericName":"belinostat","slug":"belinostat","phase":"marketed","mechanism":"Beleodaq works by blocking the enzyme that removes acetyl groups from histones, altering gene expression.","indications":["Peripheral T-cell lymphoma"],"catalyst":""},{"name":"Fusilev","genericName":"levoleucovorin","slug":"levoleucovorin","phase":"marketed","mechanism":"Fusilev works by bypassing the enzyme dihydrofolate reductase, allowing normal cell growth and DNA synthesis.","indications":["Adjunct to Fluorouracil Treatment of Colorectal Cancer","Bone Marrow Suppression due to Folic Acid Antagonism","Folic acid deficiency","Malignant tumor of stomach","Megaloblastic anemia"],"catalyst":""},{"name":"Vincristine Sulfate Liposome Injection plus rituximab","genericName":"Vincristine Sulfate Liposome Injection plus rituximab","slug":"vincristine-sulfate-liposome-injection-plus-rituximab","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Belinostat Injection","genericName":"Belinostat Injection","slug":"belinostat-injection","phase":"phase_3","mechanism":"Belinostat is a histone deacetylase (HDAC) inhibitor that blocks HDAC enzymes to promote histone acetylation, leading to altered gene expression and cancer cell death.","indications":["Peripheral T-cell lymphoma (PTCL)","Cutaneous T-cell lymphoma"],"catalyst":""},{"name":"COP","genericName":"COP","slug":"cop","phase":"marketed","mechanism":"COP is a corticosteroid that reduces inflammation and swelling in the body.","indications":["Chronic obstructive pulmonary disease (COPD)","Asthma"],"catalyst":""},{"name":"Folotyn","genericName":"Folotyn","slug":"folotyn","phase":"discontinued","mechanism":"Folate transporter 1, Proton-coupled folate transporter, Dihydrofolate reductase","indications":["Peripheral T-cell lymphoma"],"catalyst":""},{"name":"Folotyn and Leucovorin","genericName":"Folotyn and Leucovorin","slug":"folotyn-and-leucovorin","phase":"phase_2","mechanism":"Folotyn is a pegylated form of calicheamicin, a potent antitumor antibiotic that binds to DNA and inhibits RNA synthesis, while Leucovorin is a folate analog that inhibits dihydrofolate reductase, thereby increasing the effectiveness of folate-dependent drugs.","indications":["Relapsed or refractory peripheral T-cell lymphoma","Relapsed or refractory cutaneous T-cell lymphoma"],"catalyst":""},{"name":"Fusilev","genericName":"Fusilev","slug":"fusilev","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Vitamin B12","genericName":"Vitamin B12","slug":"vitamin-b12","phase":"marketed","mechanism":"Vitamin B12 acts as a coenzyme essential for DNA synthesis, myelin formation, and cellular energy metabolism.","indications":["Vitamin B12 deficiency anemia","Pernicious anemia","B12 deficiency due to malabsorption or dietary insufficiency","Neurological complications of B12 deficiency"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxORFROenR3UHdaMmJSMndiWWJUVGZtWkZXb0dMY1NMdXk1OW8xSm5UUUxWWEFVTFpIOTJzUm8tN3hsc1I5WWhMaVBGbmF1ZER3Mnk1ckdMeXlGejMxRnAyS1BkSGpiUDJQR1NaYUlPbE5hOEJnaHVDalo4TnRiV011d0lPYmZxcWhp?oc=5","date":"2026-03-02","type":"pipeline","source":"BioWorld News","summary":"Adquey finds hatchway, still more in PDE4 - BioWorld News","headline":"Adquey finds hatchway, still more in PDE4","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-16","type":"regulatory","source":"Medical Dialogues","summary":"Aurobindo Arm Acrotech Secures USFDA Nod for Atopic Dermatitis Drug ADQUEY - Medical Dialogues","headline":"Aurobindo Arm Acrotech Secures USFDA Nod for Atopic Dermatitis Drug ADQUEY","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNTjh3ZVZGRHk3S3ZJeDlaSldYOVBwVVdMZEp5c0lRMzYxeHdYUFY1QURXNkFLdU1fbWZiX3BVYm9sbURLMVJHRng1c3FvaGpaVVExZEZ2cUlzLU9OWldIbnpwOVpmcTgtMTJjaTQyUmxxWW93bmw1NUE1TFhxemlIeldsa3VFbkUtN2ZidUROcjZVOXRPNXJYVkJ30gGgAUFVX3lxTE15VjlnQzU5VDV4R1pxXzdhNUplUzlsc1hHRGRBX1VFR0ZvWnBreXhkTXdHWVlkVm5zUzM2VVJXRGxtY2RrdjczekstQTRodTdLX0M1d2lmekxCc3NaZ2FpdTRUYThvMGtobG9UMDlQcG12RkF2VVNRZUdIay14R2tiVGl4V2d6TWhRZ0xMY1RQYTYwYmdjRVoydHNXNldkRk4?oc=5","date":"2026-02-14","type":"regulatory","source":"Indian Pharma Post","summary":"FDA nod to Acrotech's new eczema treatment - Indian Pharma Post","headline":"FDA nod to Acrotech's new eczema treatment","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-13","type":"regulatory","source":"CNBC TV18","summary":"Aurobindo Pharma arm Acrotech gets FDA nod for eczema ointment ADQUEY - CNBC TV18","headline":"Aurobindo Pharma arm Acrotech gets FDA nod for eczema ointment ADQUEY - CNBC TV18","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxPY3JVRTFOODNaWExGN1N2OGFMZHFVTGJSYXpkM28xU01Sb29qVFY2YVJnOFB1TGlGMVdKNkhtY3dyQV8yZHJmZ29MckFNcVZPWUxtSjRoNFB5WmlRM3IwZzZXZm94ZlBCTFBTeEJ4U2dpR3JDbnF1d3NmLXRyZjJuYTlRNkNvZFFUelpfT1J3X25lUmZxYVZrV0I4ZDNUMklYNUd4azlJWEpKNmhiV2VvOEN6c05PUjF5WkFFNWE3aWY0cXBuVFhOQm5Ka3NET0hzdC1ibmxZQUZFTEpOak9FTHhPeURQazVuTC11VnI5NFYzVUdULVg4WTFB?oc=5","date":"2026-02-13","type":"regulatory","source":"scanx.trade","summary":"Aurobindo Pharma's Subsidiary Acrotech Receives FDA Approval for ADQUEY Ointment for Atopic Dermatitis Treatment - scanx.trade","headline":"Aurobindo Pharma's Subsidiary Acrotech Receives FDA Approval for ADQUEY Ointment for Atopic Dermatitis Treatment","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiTEFVX3lxTE5CalBHQ2ZoZ25Id2lvdEwwM1dlc3NfY3lMamdTd3dVeHo3ZDlGYnVhT2FwVFZ6TXFLci04QzU1VkxvOWFpRjhhaFNXNUI?oc=5","date":"2024-06-26","type":"pipeline","source":"Telehealth.org","summary":"27 Pharma Companies Breached Via US Pharmaceutical Giant Cencora - Telehealth.org","headline":"27 Pharma Companies Breached Via US Pharmaceutical Giant Cencora","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQQ1NiX00tUFQ5S1o1Q3FWTHZHNHRSY3FuTXlsSkhTWFpHbkh2RUI1dlBTM2NNRE1SNG1wdzZLTXRVUEhpVjF1bXhzZGFnUVJPbmU2cUdqZnZHelNRUlpMMkdTc2RTMzNRMFVURzc4dkN4TXh5MDVXS1pOZEc0bXZRbDJtYndpcF9JcklIMllOMzUxRVFRenRwSFB3TER1cWhqY3NvWGwyNkY2cjVKMW9WeGNjNkdLSVB4UEkyTURUZkl6UQ?oc=5","date":"2023-11-16","type":"regulatory","source":"Reuters","summary":"FDA panel urges Acrotech to speed up study on cancer drugs - Reuters","headline":"FDA panel urges Acrotech to speed up study on cancer drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOS2NDYl9nRUZuY0tCVnI4NE9uNHVkZUltaDlPQktMN1FMdEQtcjRUVXQ1dW1KakRlbU1FTEppVmFZekVzRThfZ0R0bnFSQjAwT1dXeElIaGlMWTM0REhZUk9EUXRPd25xdEZ1Vl9xNHNaM1ZPcnV4VThMQk92bFo1ODB6V05fQjk0RU5NaGVaanpXSkN5dHAyaTFJNEhfT3ZoYlZHbHlWN2JlX1hoeDR3UmJMU0c?oc=5","date":"2023-08-01","type":"deal","source":"Nasdaq","summary":"Mundipharma International Corporation Limited, Mundipharma Medical Company, and Acrotech Biopharma Inc. Enter Agreement to Transfer License of FOLOTYN® (Pralatrexate) in China to CASI Pharmaceuticals ","headline":"Mundipharma International Corporation Limited, Mundipharma Medical Company, and Acrotech Biopharma Inc. Enter Agreement ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTFB5dC1TZFhNRjRld0ZwVEFSOFlOeHBNaldiaUlIQkdvTmxVTW9pN083TkRXZmdvUjhrbHVrVEQ5MXZYWmUzZFY0cUFlU0R3Q3RGbm5IWFlGeHFnSWltdFdZaml5MENwMDJxUjVFNUhLRURlUQ?oc=5","date":"2023-05-22","type":"pipeline","source":"Fierce Pharma","summary":"Most expensive drugs in the US in 2023 - Fierce Pharma","headline":"Most expensive drugs in the US in 2023","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2019-03-02","type":"deal","source":"The Times of India","summary":"Aurobindo Pharma completes $300 mn deal to acquire 7 oncology products from US-based firm - The Times of India","headline":"Aurobindo Pharma completes $300 mn deal to acquire 7 oncology products from US-based firm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQdHAzbm5zNENSUmQ5dDBGanN0dk5YSWdNMXpwVWhkZXJKRUZjYk1yOXlOT2VYbUlCYXlDUUpPdWRWMnY5RGFPa2cyeFNWdlJjV3NtSEpBR2lPVjVER0xYY3VsQW84YV9qRS03OEQ0SXdRNW1hRGhJVkxnRy1TRkt1TWZmM2VxVWJtYllDQjJ4bw?oc=5","date":"2019-01-18","type":"deal","source":"Pharmaceutical Technology","summary":"Acrotech Biopharma to buy seven drugs from Spectrum for $300m - Pharmaceutical Technology","headline":"Acrotech Biopharma to buy seven drugs from Spectrum for $300m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNby1rRExUWTZyT0RzZGJYaXhqOF9ZalRYcWhIX3VjbVdvckRSV1VVLVpoUktZWmRxeU1IRWctZGFnSWVUd1ZtcDRFamVWUzUtZkFIRjBIRzdzaUV2S3NFTEVkemJsQXNPUXY3OEhPMnVUZFdmSVM2VnhvVjd4NFg3RmNnNG4xU205NHRENUdSQmJlS0Y4REhyaUh0X3c?oc=5","date":"2019-01-17","type":"pipeline","source":"BioSpace","summary":"Spectrum Pharma Sells Marketed Portfolio of 7 Drugs to Acrotech for $300 Million - BioSpace","headline":"Spectrum Pharma Sells Marketed Portfolio of 7 Drugs to Acrotech for $300 Million","sentiment":"neutral"}],"patents":[],"drugCount":9,"phaseCounts":{"marketed":4,"phase_1":1,"phase_3":1,"discontinued":2,"phase_2":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}